EC-NAPROSYN (nda020067)- (375MG,500MG)

Generic Name	NAPROXEN	Innovator	ATNAHS PHARMA US
Dosage	375MG,500MG
ParaIV Filing	No	505(b)2 Filing	No
Last Patent Expiry	Expired	NCE Excl Expiry	Expired
ODE Expiry	None	NP Expiry	None
GAIN Expiry	None	Drug Complexity	No
Indication	EC-NAPROSYN are non-steroidal anti-inflammatory drugs indicated for: the relief of the signs and symptoms of: • rheumatoid arthritis • osteoarthritis • ankylosing spondylitis • polyarticular juvenile idiopathic arthritis.

Approvals and Launches

Final Approvals	Tentative Approvals	Generic Launches
4	0	4

Other Developers

Total Other Developers	2

Drugs with Suitability

Drugs with Suitability	No

Drug Pricing

	NDA			ANDA
Dosage	Weekly	Monthly	Yearly	Yearly Up	Yearly Down
375MG	**	**	Down	-	3
500MG	**	**	Up	-	4

Drug Sales

NDA Sales Available	Total Generic Sales Available
Yes	2

Manufacturing Details of EC-NAPROSYN